Skip to main content

Glen Eagle Advisors, LLC

SEC CIK
0002029317
Latest filing
Aug 14, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
21,140
Value
$5.32M
% of portfolio
0.7%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Glen Eagle Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202621,140$5.32M0.7%−97−0.5%ReducedHolders
Q1 202621,237$4.62M0.6%+122+0.6%AddedHolders
Q4 202521,115$4.82M0.7%+2,173+11.5%AddedHolders
Q3 202518,942$4.39M0.6%−125−0.7%ReducedHolders
Q2 202519,067$3.54M0.5%−211−1.1%ReducedHolders
Q1 202519,278$4.04M0.7%+171+0.9%AddedHolders
Q4 202419,107$3.40M0.6%+830+4.5%AddedHolders
Q3 202418,277$3.61M0.6%+470+2.6%AddedHolders
Q2 202417,807$3.05M0.6%+716+4.2%AddedHolders
Q1 202417,091$3.11M0.6%−455−2.6%ReducedHolders
Q4 202317,546$2.72M0.6%−165−0.9%ReducedHolders
Q3 202317,711$2.64M0.6%+440+2.5%AddedHolders
Q2 202317,271$2.33M0.5%+762+4.6%AddedHolders
Q1 202316,509$2.63M0.7%+568+3.6%AddedHolders
Q4 202215,941$2.58M0.7%−38−0.2%ReducedHolders
Q3 202215,979$2.14M0.6%+168+1.1%AddedHolders
Q2 202215,811$2.42M0.7%+204+1.3%AddedHolders
Q1 202215,607$2.53M0.7%+295+1.9%AddedHolders
Q4 202115,312$2.07M0.5%−245−1.6%ReducedHolders
Q3 202115,557$1.68M0.5%+1,959+14.4%AddedHolders
Q2 202113,598$1.53M0.5%+479+3.7%AddedHolders
Q1 202113,119$1.41M0.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.